Literature DB >> 26212351

Dosimetric study of volumetric arc modulation with RapidArc and intensity-modulated radiotherapy in patients with cervical cancer and comparison with 3-dimensional conformal technique for definitive radiotherapy in patients with cervical cancer.

Jean-Baptiste Guy1, Alexander T Falk2, Pierre Auberdiac3, Lysian Cartier1, Alexis Vallard1, Edouard Ollier4, Jane-Chloé Trone1, Moustapha Khodri1, Cyrus Chargari5, Nicolas Magné6.   

Abstract

INTRODUCTION: For patients with cervical cancer, intensity-modulated radiation therapy (IMRT) improves target coverage and allows dose escalation while reducing the radiation dose to organs at risk (OARs). In this study, we compared dosimetric parameters among 3-dimensional conformal radiotherapy (3D-CRT), "step-and-shoot" IMRT, and volumetric intensity-modulated arc radiotherapy (VMAT) in a series of patients with cervical cancer receiving definitive radiotherapy. Computed tomography (CT) scans of 10 patients with histologically proven cervical cancer treated with definitive radiation therapy (RT) from December 2008 to March 2010 at our department were selected for this study. The gross tumor volume (GTV) and clinical target volume (CTV) were delineated following the guidelines of the Gyn IMRT consortium that included cervix, uterus, parametrial tissues, and the pelvic nodes including presacral. The median age was 57 years (range: 30 to 85 years). All 10 patients had squamous cell carcinoma with Federation of Gynecology and Obstetrics (FIGO) stage IB-IIIB. All patients were treated by VMAT. OAR doses were significantly reduced for plans with intensity-modulated technique compared with 3D-CRT except for the dose to the vagina. Between the 2 intensity-modulated techniques, significant difference was observed for the mean dose to the small intestine, to the benefit of VMAT (p < 0.001). There was no improvement in terms of OARs sparing for VMAT although there was a tendency for a slightly decreased average dose to the rectum: - 0.65Gy but not significant (p = 0.07). The intensity modulation techniques have many advantages in terms of quality indexes, and particularly OAR sparing, compared with 3D-CRT. Following the ongoing technologic developments in modern radiotherapy, it is essential to evaluate the intensity-modulated techniques on prospective studies of a larger scale.
Copyright © 2016 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Dosimetry; IMRT; VMAT

Mesh:

Year:  2015        PMID: 26212351     DOI: 10.1016/j.meddos.2015.06.002

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  7 in total

1.  A comparative dosimetric study of cervical cancer patients with para-aortic lymph node metastasis treated with volumetric modulated arc therapy vs. 9-field intensity-modulated radiation therapy.

Authors:  Yaqin Wu; Biqing Zhu; Jingjing Han; Hanzi Xu; Zhen Gong; Yongqin Yang; Jian Huang; Emei Lu
Journal:  Ann Transl Med       Date:  2019-11

2.  Early Clinical Outcomes, Patterns of Failure, and Acute Haematologic Toxicity of Image-Guided Volumetric Modulated Arc Therapy (IG-VMAT) in the Definitive Treatment of Locally Advanced Carcinoma Cervix.

Authors:  Irfan Ahmad; Kundan Singh Chufal; Irfan Bashir; Chandi Prasad Bhatt; Ram Bajpai; Lalit Sharma; Sandeep Rathour
Journal:  Clin Med Insights Oncol       Date:  2018-06-27

3.  Dosimetric comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy in patients with cervical cancer: a meta-analysis.

Authors:  Wei Bai; Changgui Kou; Weiying Yu; Yuanyuan Li; Wanqing Hua; Lei Yu; Jianfeng Wang
Journal:  Onco Targets Ther       Date:  2018-10-18       Impact factor: 4.147

4.  Clinical acceptability of fully automated external beam radiotherapy for cervical cancer with three different beam delivery techniques.

Authors:  Dong Joo Rhee; Anuja Jhingran; Kai Huang; Tucker J Netherton; Nazia Fakie; Ingrid White; Alicia Sherriff; Carlos E Cardenas; Lifei Zhang; Surendra Prajapati; Stephen F Kry; Beth M Beadle; William Shaw; Frederika O'Reilly; Jeannette Parkes; Hester Burger; Chris Trauernicht; Hannah Simonds; Laurence E Court
Journal:  Med Phys       Date:  2022-07-26       Impact factor: 4.506

5.  From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience.

Authors:  Sophie Espenel; Max-Adrien Garcia; Jane-Chloé Trone; Elodie Guillaume; Annabelle Harris; Amel Rehailia-Blanchard; Ming Yuan He; Sarra Ouni; Alexis Vallard; Chloé Rancoule; Majed Ben Mrad; Céline Chauleur; Guy De Laroche; Jean-Baptiste Guy; Pablo Moreno-Acosta; Nicolas Magné
Journal:  Radiat Oncol       Date:  2018-02-02       Impact factor: 3.481

6.  Radical radiotherapy in patients with cervix uteri carcinoma: experience of Ondokuz Mayis University.

Authors:  Alparslan Serarslan; Bilge Gursel; Deniz Meydan; Nilgun Ozbek Okumus
Journal:  BMC Cancer       Date:  2019-12-12       Impact factor: 4.430

7.  IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study.

Authors:  Zoltán Lőcsei; Klára Sebestyén; Zsolt Sebestyén; Eszter Fehér; Dorottya Soltész; Zoltán Musch; László Csaba Mangel
Journal:  Pathol Oncol Res       Date:  2021-03-24       Impact factor: 3.201

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.